Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days’ exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars – particularly in curative cancer treatment, where they are relatively recent therapeutic options. ‘Fast Facts: Biosimilars in Hematology and Oncology’ provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients.
€0.00
यह ईबुक खरीदें और 1 और मुफ़्त पाएं!
भाषा अंग्रेज़ी ● स्वरूप EPUB ● पेज 128 ● ISBN 9781912776221 ● फाइल का आकार 5.5 MB ● प्रकाशक S. Karger AG ● शहर Basel ● देश CH ● प्रकाशित 2020 ● संस्करण 1 ● डाउनलोड करने योग्य 24 महीने ● मुद्रा EUR ● आईडी 7729225 ● कॉपी सुरक्षा Adobe DRM
एक DRM सक्षम ईबुक रीडर की आवश्यकता है
एक ही लेखक से अधिक ईबुक / संपादक
46,262 इस श्रेणी में ईबुक
